PMGC HOLDINGS INC. Retained Earnings
PMGC HOLDINGS INC. (ELAB) had Retained Earnings of -$28.93 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$28.93M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$25.98M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$21.02M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$18.03M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$28.93M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$25.98M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$21.02M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$18.03M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$15.44M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$14.88M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$13.27M 10-K · filed 2026-03-30 | |
| 2024-09-30 | -$11.33M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$9.83M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$8.42M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$7.02M 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$5.87B 10-Q · filed 2023-12-11 | |
| 2022-12-31 | -$2.72M 10-K · filed 2024-03-29 | -$2.72B 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |